Larsen & Toubro (L&T) Noninvasive Blood Pressure Module Performance Validation

NCT ID: NCT01097603

Last Updated: 2010-04-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Study Classification

OBSERVATIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To validate accuracy of the readings of noninvasive blood pressure (NIBP) module with sphygmomanometer as per the requirements of AAMI SP10:2002. This study is for adult and pediatric population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subjects
* Age between 1 - 60 yrs
* Both genders
* Consenting for the study


* Patients of hypertensive, ICU and in patients of different diseases
* Age between 1 - 80 yrs
* Both genders
* Consenting for the study

Exclusion Criteria

* Subjects suffering from cardiorespiratory, neurological or endocrinal disorders
* Subjects with alcohol abuse/dependance
* Female subjects who are pregnant or lactating
* Subjects with pace maker implantations

Subjects: Diseased subjects


* Healthy volunteers
Minimum Eligible Age

1 Year

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Larsen & Toubro Limited

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

LARSEN & TOUBRO LIMITED

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LTMED01-0310

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.